Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for the treatment of a beta-catenin-associated disease or disorder

Compositions and methods for the treatment of a beta-catenin-associated disease or disorder

US Patent 10821112 · Granted Nov 3, 2020

Estimated economic value: $24,627,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for inhibiting LPA expression2025
Compositions and methods for inhibiting LPA expression2025
Compositions and methods for modulating PNPLA3 expression2024
Reducing beta-catenin and IDO expression to potentiate immunotherapy2023
Reducing beta-catenin expression to potentiate immunotherapy2023
Reducing beta-catenin expression to potentiate immunotherapy2023
Compositions and methods for the treatment of a beta-catenin-associated disease 2022
Compositions and methods for the treatment of a beta-catenin-associated disease 2022
Compositions and methods for inhibiting HMGB1 expression2022
Methods for treating hepatitis B infection2022
Organic compositions to treat EPAS1-related diseases2022
Methods for treating hepatitis B infection2021